Who Owns GoodRx?
GoodRx is an independent publicly traded American healthcare technology company listed on NASDAQ under the ticker symbol GDRX. Founded in 2011 by Trevor Bezdek, Doug Hirsch, and Scott Boucher, GoodRx operates as the leading platform for prescription savings in the United States, headquartered in Santa Monica, California.
Parent Company
Founded
2011
Status
Publicly Traded
Headquarters
freemass marketGlobalall-agescommunity health supportprescription efficiencyhealthcare accessibilitydigital health innovationOfficial Website
Who Owns GoodRx?
- Parent Company: GoodRx Holdings, Inc.
- Ownership Type: Public corporation
- Company Type: Publicly Traded
- Stock Ticker: Nasdaq: GDRX
| Brand | Parent Company | Ownership Type |
|---|---|---|
| GoodRx | GoodRx Holdings, Inc. | Public corporation |
Where to Buy
Disclosure: We may earn commission from purchases
GoodRx on AmazonHistory of GoodRx
- Founded: 2011
- Founders: Trevor Bezdek, Doug Hirsch, Scott Boucher
GoodRx was founded in 2011 by Trevor Bezdek, Doug Hirsch, and Scott Boucher with the mission to help Americans find affordable healthcare options. This founding vision demonstrated exceptional insight into the growing demand for healthcare technology solutions while establishing a distinctive approach that would define the healthcare category for generations. The platform was created to provide transparency in prescription drug pricing and offer discount coupons to reduce medication costs. This strategic positioning demonstrated GoodRx's exceptional ability to create differentiated healthcare solutions while maintaining consistent brand positioning and quality standards that would define the brand for decades.
The company quickly gained popularity by providing consumers with easy access to prescription drug prices at local pharmacies and discount coupons that could significantly reduce out-of-pocket costs. This period of excellence demonstrated GoodRx's exceptional ability to scale operations while maintaining consistent brand positioning and quality standards across multiple healthcare segments. GoodRx expanded its services to include telehealth consultations and healthcare provider information. This strategic diversification demonstrated GoodRx's exceptional ability to serve multiple consumer segments while maintaining its core brand identity and cultural significance in the healthcare technology industry. This continued success represents a significant milestone in the evolution of healthcare technology and consumer-focused prescription solutions.
About GoodRx Holdings, Inc.
What does GoodRx own?
GoodRx owns a portfolio of digital healthcare brands and services. These include the core GoodRx platform for prescription drug price comparison and discount coupons, GoodRx Gold (subscription service for enhanced savings), GoodRx Care (telehealth platform), GoodRx for Weight Loss (condition-specific subscription for GLP-1 treatments), and initiatives including RxSmartSaver and Community Link. The company does not own pharmacies or pharmaceutical manufacturers but partners with them.
Is GoodRx publicly traded?
Yes, GoodRx Holdings, Inc. is publicly traded on the Nasdaq stock exchange under ticker GDRX. The company went public in September 2020, raising approximately $1.1 billion in its IPO. GoodRx has a dual-class share structure with 108.6 million Class A shares and 234.0 million Class B shares as of February 2026. Class B shares carry ten votes per share, giving founders and early investors disproportionate voting control. The market value of non-affiliate shares was approximately $423.2 million as of June 2025.
Who is the CEO of GoodRx?
Wendy Barnes has served as President and CEO of GoodRx since January 1, 2025. She succeeded Interim CEO Scott Wagner. Barnes has over 30 years of experience in the pharmacy and medical benefit industry, including roles as CEO of RxBenefits (2022 to 2024) and President of Express Scripts Pharmacy (2019 to 2022). She holds a B.S. in Biochemistry from the United States Air Force Academy and an MBA from the University of Alaska Anchorage.
Who founded GoodRx?
GoodRx was founded in 2011 by Trevor Bezdek, Doug Hirsch, and Scott Borchert in Santa Monica, California. The founders recognized that prescription drug prices vary widely between pharmacies and built a platform to help consumers compare prices and access discount coupons. Bezdek serves as Chairman of the Board. The founders wanted to make healthcare more affordable for Americans.
Where is GoodRx headquartered?
GoodRx is headquartered in Santa Monica, California, USA. The company has been based in Santa Monica since its founding in 2011. GoodRx operates primarily in the United States, with approximately 1,000 employees. The company does not have international operations.
What is GoodRx's revenue?
GoodRx reported FY2025 revenue of $796.9 million, up 1 percent from $792.3 million in FY2024. Net income was $30.4 million, and adjusted EBITDA was $270.5 million with a 33.9 percent margin. Revenue is divided into prescription transactions ($544.0 million), pharma direct ($151.4 million, up 41 percent), and subscriptions ($83.8 million). For FY2026, GoodRx guided to revenue of $750 to $780 million, representing a 2 to 6 percent decline.
What was the FTC action against GoodRx?
In February 2023, the FTC filed an enforcement action against GoodRx for sharing users' sensitive health information with Facebook, Google, and Criteo for advertising purposes, despite promising users it would never share such data. GoodRx agreed to pay a $1.5 million civil penalty and stop sharing health data with third parties for advertising. A related class action lawsuit resulted in a revised $32 million settlement in December 2025. The FTC's action was the first enforcement under its Health Breach Notification Rule.
- Founded: 2011
- Headquarters: Santa Monica, California, USA
- Company Type: Publicly Traded
- Stock: Nasdaq: GDRX
- Revenue: $796.9M (FY2025)
- Employees: ~1,000
Where Is GoodRx Made / Based?
- Headquarters: Santa Monica, California, USA
- Manufacturing / Operations: United States
GoodRx Categories & Tags
GoodRx Sustainability & Ethics
As a healthcare technology platform, GoodRx's sustainability profile focuses on data privacy, healthcare access, and ethical business practices. The company has committed to cybersecurity and data protection standards.
GoodRx does not hold cruelty-free or vegan certifications, as these certifications are not applicable to healthcare technology platforms.
GoodRx publishes information on data security and privacy practices. The company maintains compliance with healthcare data protection regulations including HIPAA.
Awards & Recognition
GoodRx has received recognition for healthcare innovation and accessibility:
- Healthcare Innovation: GoodRx has received recognition for innovation in prescription drug price transparency.
- Consumer Choice: The platform has received awards for consumer satisfaction and healthcare affordability solutions.
- Cybersecurity: GoodRx earned 2026 cybersecurity certification demonstrating commitment to data protection.
GoodRx Recalls & Controversies
Data Privacy Concerns: GoodRx has faced questions about user data privacy and how prescription information is handled. The company maintains HIPAA compliance and has implemented privacy controls.
Pharmacy Relationship Questions: Questions have been raised about GoodRx's relationships with pharmacies and how discount programs affect pharmacy profitability.
Market Valuation Decline: GoodRx's market capitalization has declined significantly from its 2020 IPO peak, reflecting competitive pressures in the healthcare technology market.
GoodRx Ownership: Pros & Cons
Advantages
- +Market leader in U.S. prescription drug price transparency and savings
- +Direct consumer access with strong brand recognition
- +Independent public company with access to capital markets
- +Expansion into telehealth and broader healthcare services
- +Technology-driven approach to healthcare affordability
Considerations
- -Significant decline in market capitalization since 2020 IPO peak
- -Dependence on pharmacy participation and discount acceptance
- -Competition from other prescription savings platforms and pharmacy programs
- -Regulatory oversight of healthcare technology and pricing information
- -Balance between consumer savings and pharmacy profitability
Frequently Asked Questions About GoodRx
Sources & Further Reading
Competitors to GoodRx
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Ge Healthcare | USA | 1994 | Premium | Global | All-ages |
Competitive Analysis
Market Positioning: GoodRx competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Independent Alternatives to GoodRx
Looking for brands with different ownership structures? These similar brands are not owned by GoodRx Holdings, Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsPharmacy Direct
Owned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
online-pharmacymail-orderdigital-health
Privately Owned
Pharmacy Direct is privately owned, unlike GoodRx which is under a publicly traded parent company.
Healthcare PharmaceuticalsGE HealthCare
Owned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
healthcare-technologymedical-imagingdiagnostics
Publicly Traded
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsHerbalife
Owned by Herbalife Ltd.
Global nutrition and weight-management brand owned by Herbalife Ltd. and sold through independent distributors in more than 90 markets.
nutritiondietary-supplementsweight-management
Publicly Traded
Herbalife operates independently without a large parent corporation.
Healthcare PharmaceuticalsRetavase
Owned by EKR Therapeutics, Inc.
Retavase (reteplase) is a prescription thrombolytic medication indicated for acute ST-elevation myocardial infarction. Administered as two 10-unit intravenous bolus injections 30 minutes apart. Currently marketed by Chiesi USA.
pharmaceuticalthrombolyticreteplase
Privately Owned
Retavase is privately owned, unlike GoodRx which is under a publicly traded parent company.
Healthcare PharmaceuticalsTirosint
Owned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
levothyroxinehypothyroidismthyroid
Privately Owned
Tirosint is privately owned, unlike GoodRx which is under a publicly traded parent company.
Healthcare PharmaceuticalsPhilips
Owned by Koninklijke Philips N.V.
Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.
healthcare-technologyelectronicsmedical-devices
Publicly Traded
Philips operates independently without a large parent corporation.
GoodRx Holdings, Inc. Stock Information
Jobs at GoodRx Holdings, Inc.
Latest News About GoodRx
Related Articles About GoodRx
View more articles
Entertainment
Toy Brand Ownership: From LEGO to Hasbro
LEGO is family-owned by the Kirk Kristiansens. Hasbro and Mattel are Wall Street-owned. Bandai Namco owns Tamagotchi. Discover who owns the biggest toy brands and why it matters. Explore our database.
Who Brands StaffSep 4, 2026
ToysLegoHasbro
Pop Culture
Video Game Brands and Their Corporate Parents
EA sold for $55B to Saudi Arabia's PIF, Silver Lake and Kushner's Affinity. Microsoft bought Activision Blizzard for $75.4B. Tencent owns Riot, Supercell, and stakes in Epic. Sony bought Bungie for $3.6B. Discover video game brands and their corporate parents.
Who Brands StaffSep 3, 2026
Video GamesAcquisitionsEa
Pop Culture
Brands That Appeared in Super Bowl Ads Then Got Acquired
Poppi ran a Super Bowl ad in February 2025 and PepsiCo bought it for $1.95B. Grubhub debuted in Super Bowl LX after Wonder acquired it for $650M. WeatherTech ran its 14th ad. Discover brands that appeared in Super Bowl ads then got acquired.
Who Brands StaffSep 2, 2026
Super BowlAcquisitionsPoppi
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Branddermatology
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription
Brandpharmaceutical
Activase
Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.
Brand in Healthcare & Pharmaceuticals
thrombolyticstroke-treatment